Ceretype Neuromedicine, Inc.
PrivateLast Round
Seed
Jan 4, 2024
Total Funding Raised
$3.67M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ceretype Neuromedicine, Inc. operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Seed round in January 2024.
Ceretype Neuromedicine, Inc. is a biotechnology company that provides a functional MRI (fMRI) platform to analyze brain circuitry and develop biomarkers for psychiatric and neurological drug development.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical Imaging, Biotechnology, Medical AI, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ceretype Neuromedicine, Inc. Comparables
Compare Ceretype Neuromedicine, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Karavela | 82% | |
| ADM Diagnostics, Inc. | 81% | |
| IXICO plc | 78% |
For institutional investors. Book with your work email.
Ceretype Neuromedicine, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 4, 2024 | ||||
| Accelerator | Mar 2, 2023 | ||||
| Seed | Nov 8, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ceretype Neuromedicine, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Catalytic Impact Foundation | Seed |
| One Mind Accelerator | Seed, Accelerator |
| Leafy Tunnel | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 72% MoM.
- Apr 21, 2026
Monthly visitors increased 174% MoM.
For institutional investors. Book with your work email.
Ceretype Neuromedicine, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ceretype Neuromedicine, Inc.'s valuation, stock price, and market status.
Is Ceretype Neuromedicine, Inc. a public or private company?
Ceretype Neuromedicine, Inc. is a private company.
What is the current stock price of Ceretype Neuromedicine, Inc.?
Ceretype Neuromedicine, Inc. is a private company, so its shares have no public market price. Caplight tracks Ceretype Neuromedicine, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ceretype Neuromedicine, Inc. worth (valuation)?
Valuation information for Ceretype Neuromedicine, Inc. is not publicly available.
Can I buy Ceretype Neuromedicine, Inc. stock?
Ceretype Neuromedicine, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ceretype Neuromedicine, Inc.'s last funding round?
Ceretype Neuromedicine, Inc.'s most recent funding round was Seed on January 4, 2024.
Who are the main investors in Ceretype Neuromedicine, Inc.?
Key investors in Ceretype Neuromedicine, Inc. include Catalytic Impact Foundation, One Mind Accelerator, Leafy Tunnel.
Will Ceretype Neuromedicine, Inc. IPO soon?
No public IPO plans have been announced for Ceretype Neuromedicine, Inc..
How can I track Ceretype Neuromedicine, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Ceretype Neuromedicine, Inc.'s shares on secondary markets.